Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CYTK

Cytokinetics, Incorporated

Healthcare · USD

Set alert

Price alert · CYTK

All alert types
62.99 USD -0.32 -0.51%
As of Oct 30, 2026 Extended hours 62.99 0.00%
Bid
63.00 × 2
Ask
63.06 × 2
62.55 Day range 64.50
59.19 52-week range 87.26
YTD
-0.87%
1 year
+1.19%
Open
63.44
Prev close
63.31
Mkt cap
8.76B
Vol
1.26M
Avg vol
1.92M
EPS
-7.22
P/E
0.00
Div yield
0.00%
More statistics
Low
62.55
High
64.50
Forward P/E
-14.30
Beta
0.41
Short ratio
8.18
Inst. own
126.00%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
67.78
200-d avg
70.09
1y target
107.26

5D chart

Chart tools
Interval
1m5m15m30m
CYTK five-day price chart60.161.162.063.064.0Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-1.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -9.7×
FY 2016: 29.6×FY 2017: -3.1×FY 2018: -3.2×FY 2019: -4.1×FY 2020: -10.5×FY 2021: -16.3×FY 2022: -10.6×FY 2023: -15.3×FY 2024: -8.9×FY 2025: -9.7×
FY 2016 5y median -10.6× FY 2025
P/S 86.6×
FY 2016: 4.6×FY 2017: 30.1×FY 2018: 10.9×FY 2019: 22.7×FY 2020: 24.0×FY 2021: 49.8×FY 2022: 43.5×FY 2023: 1070×FY 2024: 285×FY 2025: 86.6×
FY 2016 5y median 86.6× FY 2025
P/B -11.6×
FY 2016: 5.1×FY 2017: 3.7×FY 2018: 13.3×FY 2019: -55.9×FY 2020: 11.8×FY 2021: 14.4×FY 2022: -38.1×FY 2023: -20.9×FY 2024: -38.9×FY 2025: -11.6×
FY 2016 5y median -20.9× FY 2025
P/FCF -14.3×
FY 2016: 13.7×FY 2017: -3.8×FY 2018: -3.4×FY 2019: -6.5×FY 2020: -636×FY 2021: -18.3×FY 2022: -13.2×FY 2023: -19.4×FY 2024: -13.2×FY 2025: -14.3×
FY 2016 5y median -14.3× FY 2025
EV/EBITDA -11.3×
FY 2016: 29.9×FY 2017: -2.8×FY 2018: -4.1×FY 2019: -7.6×FY 2020: -16.1×FY 2021: -19.9×FY 2022: -14.5×FY 2023: -19.1×FY 2024: -12.1×FY 2025: -11.3×
FY 2016 5y median -14.5× FY 2025
EV/Sales 99.8×
FY 2016: 4.2×FY 2017: 23.1×FY 2018: 10.9×FY 2019: 26.4×FY 2020: 25.0×FY 2021: 52.0×FY 2022: 50.8×FY 2023: 1156×FY 2024: 323×FY 2025: 99.8×
FY 2016 5y median 99.8× FY 2025
FCF Yield -7.0%
FY 2016: 7.3%FY 2017: -26.0%FY 2018: -29.7%FY 2019: -15.3%FY 2020: -0.2%FY 2021: -5.5%FY 2022: -7.6%FY 2023: -5.2%FY 2024: -7.6%FY 2025: -7.0%
FY 2016 5y median -7.0% FY 2025

Profitability

Gross Margin 88.5%
FY 2016: 39.5%FY 2017: -575.5%FY 2018: -183.0%FY 2019: -220.5%FY 2020: -73.7%FY 2021: -127.1%FY 2022: -154.6%FY 2023: -4284.1%FY 2024: -1737.2%FY 2025: 88.5%
FY 2016 5y median -154.6% FY 2025
Operating Margin -695.4%
FY 2016: 17.6%FY 2017: -848.3%FY 2018: -282.3%FY 2019: -368.0%FY 2020: -168.3%FY 2021: -264.5%FY 2022: -342.8%FY 2023: -6589.7%FY 2024: -2902.7%FY 2025: -695.4%
FY 2016 5y median -695.4% FY 2025
Net Margin -891.6%
FY 2016: 15.5%FY 2017: -955.9%FY 2018: -337.4%FY 2019: -452.9%FY 2020: -228.0%FY 2021: -305.7%FY 2022: -411.2%FY 2023: -6988.6%FY 2024: -3191.1%FY 2025: -891.6%
FY 2016 5y median -891.6% FY 2025
ROE 119.0%
FY 2016: 17.4%FY 2017: -116.3%FY 2018: -409.8%FY 2019: 1112.7%FY 2020: -112.3%FY 2021: -88.3%FY 2022: 360.5%FY 2023: 136.2%FY 2024: 435.5%FY 2025: 119.0%
FY 2016 5y median 136.2% FY 2025
ROIC -47.7%
FY 2016: 13.4%FY 2017: -43.2%FY 2018: -46.4%FY 2019: -36.8%FY 2020: -18.6%FY 2021: -23.8%FY 2022: -34.3%FY 2023: -66.2%FY 2024: -42.8%FY 2025: -47.7%
FY 2016 5y median -42.8% FY 2025
ROA -55.1%
FY 2016: 9.7%FY 2017: -43.3%FY 2018: -50.3%FY 2019: -42.0%FY 2020: -23.8%FY 2021: -25.6%FY 2022: -38.3%FY 2023: -63.8%FY 2024: -42.1%FY 2025: -55.1%
FY 2016 5y median -42.1% FY 2025

Growth (YoY)

Revenue 376.6%
FY 2016: 271.3%FY 2017: -87.4%FY 2018: 135.6%FY 2019: -14.7%FY 2020: 107.8%FY 2021: 26.2%FY 2022: 34.3%FY 2023: -92.0%FY 2024: 145.3%FY 2025: 376.6%
FY 2016 FY 2025
Operating Income -14.2%
FY 2016: 150.0%FY 2017: -706.8%FY 2018: 21.6%FY 2019: -11.2%FY 2020: 5.0%FY 2021: -98.3%FY 2022: -74.0%FY 2023: -53.1%FY 2024: -8.1%FY 2025: -14.2%
FY 2016 FY 2025
EPS (diluted) -24.3%
FY 2016: 140.2%FY 2017: -764.1%FY 2018: 24.7%FY 2019: -32.8%FY 2020: 23.9%FY 2021: -42.1%FY 2022: -54.6%FY 2023: -25.9%FY 2024: 3.5%FY 2025: -24.3%
FY 2016 FY 2025
Free Cash Flow -33.8%
FY 2016: 718.9%FY 2017: -395.7%FY 2018: 2.4%FY 2019: 8.4%FY 2020: 97.7%FY 2021: -8975.1%FY 2022: -62.4%FY 2023: -33.7%FY 2024: 3.8%FY 2025: -33.8%
FY 2016 FY 2025

Financial Health

Current Ratio 4.5×
FY 2016: 4.8×FY 2017: 8.5×FY 2018: 9.4×FY 2019: 9.0×FY 2020: 15.2×FY 2021: 7.5×FY 2022: 9.4×FY 2023: 6.1×FY 2024: 6.2×FY 2025: 4.5×
FY 2016 5y median 6.2× FY 2025
Quick Ratio 4.5×
FY 2016: 4.8×FY 2017: 8.5×FY 2018: 9.7×FY 2019: 9.0×FY 2020: 15.2×FY 2021: 7.5×FY 2022: 9.4×FY 2023: 6.1×FY 2024: 6.2×FY 2025: 4.5×
FY 2016 5y median 6.2× FY 2025
Debt / Equity -1.9×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 1.6×FY 2019: -12.4×FY 2020: 1.2×FY 2021: 1.1×FY 2022: -7.0×FY 2023: -2.0×FY 2024: -5.8×FY 2025: -1.9×
FY 2016 5y median -2.0× FY 2025
Net Debt / EBITDA -1.5×
FY 2016: -2.6×FY 2017: 0.9×FY 2018: -0.0×FY 2019: -1.1×FY 2020: -0.6×FY 2021: -0.9×FY 2022: -2.1×FY 2023: -1.4×FY 2024: -1.4×FY 2025: -1.5×
FY 2016 5y median -1.4× FY 2025
Interest Coverage -5.9×
FY 2016: 8.4×FY 2017: -6.7×FY 2018: -4.1×FY 2019: -3.6×FY 2020: -2.4×FY 2021: -6.4×FY 2022: -6.3×FY 2023: -8.6×FY 2024: -6.2×FY 2025: -5.9×
FY 2016 5y median -6.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31